Trial NCT01658527

View at ClinicalTrials.gov 
Org. Study IDs: EORTC-1211-GUCG-IG
Secondary IDs: 2012-002122-67

Last trial update was posted on 2016-06-10

MeSH Interventions

Bicalutamide

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Prostate Cancer

Stopping Reasons

Pharmaceutical company has terminated orteronel (TAK-700) development for Prostate Cancer

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID